#1254863
Microgenics #0225

Toxicology Reagent DRI® Barbiturates (BAR) CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Toxicology Reagent
Brand: DRI®

REAGENT, IMMUNOASSAY DRI BARBITURATE 100ML D/S

No Image

Compare

Product Specifications

McKesson #

1254863

Manufacturer #

0225

Brand

DRI®

Manufacturer

Microgenics

Country of Origin

Unknown

Application

Toxicology Reagent

Buy American Act (BAA) Compliant

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Form

Ready-to-Use Liquid

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Urine Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Method

Homogeneous Enzyme Immunoassay (HEIA)

Test Name

Barbiturates (BAR)

Test Type

Single Drug

Trade Agreement Act (TAA) Compliant

UNSPSC Code

41116007

Volume

100 mL

Features

The DRI Barbiturate Assay is intended for the qualitative and semiquantitative determination of barbiturates in human urine with 200 ng/mL as cutoff calibrator
DRI Barbiturate Assay is a homogeneous enzyme immunoassay using ready-to-use liquid reagents
Analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates at 340 nm and timing the reaction accurately can be used to perform this assay
Qualitative or semi-quantitative options for results
Excellent correlation to GC/MS